Advances in Nanomaterials for Drug Delivery

Affiliations

¹Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran

²Department of Medical Nanotechnology, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran

³Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, United States of America

⁴Department of Clinical Biochemistry and Isfahan Pharmaceutical Research Center, Isfahan University of Medical Science, Isfahan, Iran

⁵Department of Chemistry, Shahid Beheshti University, Tehran, Iran

⁶Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, United States of America

⁷Department of Dermatology, Harvard Medical School, Boston, MA, 02115, United States of America

⁸Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, 02139, United States of America

About the authors

Mahdi Karimi^{1, 2, 3} received his BSc in medical laboratory science from the Iran University of Medical Sciences. He then earned an MSc in medical biotechnology from Tabriz University of Medical Sciences and joined the Tarbiat Modares University as a PhD student in nanobiotechnology. He went on to join the department of medical nanotechnology at Iran University of Medical Sciences as an assistant professor.

Maryam Rad Mansuri⁴ received her BSc degree in biology from Tabriz University in 2008. In 2013 she received an MSc degree in clinical biochemistry from Isfahan University of Medical Science. After graduation, she continued her studies in the design of therapeutic nanoparticles for drug delivery. Her current research interests include biomimetic nanoparticle design in drug/gene delivery systems.

Navid Rabiee⁵ graduated with a BSc from Shahid Beheshti University, Iran, in 2016. In 2018, he received his MSc in inorganic chemistry from Shahid Beheshti University, Iran. In 2017, he joined the Advances Nanobiotechnology and Nanomedicine Research Group to collaborate with Mahdi Karimi's research lab at the Iran University of Medical Science, in association Michael R Hamblin from Harvard Medical School, USA.

Michael R Hamblin^{6, 7, 8} is a principal investigator at the Wellman Center for Photomedicine, Massachusetts General Hospital, and an associate professor at Harvard Medical School. He is the Editor-in-Chief of Photobiomodulation, Photomedicine and Laser Surgery and he has authored or edited 23 textbooks on photodynamic therapy and photomedicine.